Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bayer Appeals Roundup Lawsuits to U.S. Supreme Court Again Third Roundup Supreme Court appeal comes as the company continues to lobby various states to pass laws that would shield it from liability in lawsuits. April 7, 2025 Irvin Jackson Add Your Comments Bayer is making a third attempt to get the U.S. Supreme Court to hear an appeal that seeks to prevent Roundup lawsuits from being pursued by former users diagnosed with non-Hodgkin’s lymphoma, while the company is still trying to convince a number of state legislatures to pass laws that would grant it immunity for failing to warn about potential side effects from the weedkiller. Over the past decade Bayer, and its Monsanto subsidiary, have faced more than 120,000 Roundup cancer lawsuits, each alleging that the manufacturer failed to disclose that the active ingredient glyphosate may cause users to develop non-Hodgkin’s lymphoma and other injuries. While the company has paid more than $10 billion in Roundup settlements over the past few years, Bayer and Monsanto continue to face thousands of active lawsuits being pursued throughout the U.S. court system, and new claims continue to be brought as former users of the weed killer develop non-Hodgkin’s lymphoma. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION On Friday, Bayer filed a Writ of Certiorari (PDF), petitioning the U.S. Supreme Court to decide whether all Roundup failure-to-warn claims should be dismissed based on federal preemption, arguing that the company could not have updated the product’s labels without approval from the U.S. Environmental Protection Agency (EPA), which, to date, has stated that glyphosate is not a cancer-causing chemical. That position directly contradicts determinations made by renowned health experts, including the World Health Organization’s International Agency for Research on Cancer (IARC), which decided to classify glyphosate in Roundup as a probable cancer-causing agent in 2015. Roundup Supreme Court Appeal This is the company’s third attempt to get the U.S. Supreme Court to weigh in on the litigation, with the petition coming after the Missouri Supreme Court rejected a similar Roundup appeal in February over a jury verdict handed down in October 2023, which awarded John Durnell $1.25 million in damages. Durnell indicated at trial that he began using Roundup in 1966, as part of the Soulard Restoration Project in St. Louis. As a direct result of the exposure, he claimed that he was diagnosed with non-Hodgkin’s lymphoma several years later, and a state court jury agreed. Bayer indicates that differences of opinion between the Ninth and Eleventh Circuit Courts, and the Missouri Supreme Court, makes Durnell’s case ripe for review by the U.S. Supreme Court. “The company argues that a split among federal circuit courts in the Roundup personal injury litigation, on the cross-cutting question of whether federal law preempts state-based failure-to-warn claims, warrants review and resolution by the country’s top court,” according to a press release issued by Bayer on April 4. “The stakes could not be higher as tens of thousands of Roundup cases are pending in state and federal courts, all of which rest on state-based failure-to-warn claims that should be preempted by federal law.” The Supreme Court has already rejected Bayer’s Roundup appeals before. The company petitioned the Court to review another Roundup trial defeat, involving an $87 million verdict awarded to a California couple, Alva and Alberta Pilliod in May 2019. However, the Supreme Court refused to review the case in June 2022. This followed a previous refusal to review another Roundup appeal in March 2019. The Court provided no comment about the reasons why the petitions were rejected in either case, which is not uncommon. At the time, Bayer indicated it disagreed with the ruling and that it would look for future opportunities to bring the litigation before the high court. The company now indicates that recent differences of opinion between the Ninth and Eleventh Circuit Courts has provided that opportunity. Bayer Lobbies States for Roundup Lawsuit Immunity While seeking Supreme Court review, Bayer is also continuing with efforts to convince state lawmakers to pass legislation that would shield the company from Roundup cancer lawsuits. On April 2, the Tennessee General Assembly’s Senate passed SB 0527, voting 21-7 to make pesticide companies immune from civil liability lawsuits in that state. The bill still needs to be passed by the state House, which will hold a judiciary committee hearing on the measure on April 9. If it makes it through the house, it would then need to be signed into law by the governor. The Tennessee version of the bill indicates that manufacturers of pesticides approved by the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) are not liable to civil actions linked to its labeling, if that label was approved by the EPA. At least 300 Roundup lawsuits have been filed in Tennessee. However, the day the bill was passed, an amendment was added that indicates the protections do not apply “if a determination has been made by the EPA that a manufacturer knowingly withheld, concealed, misrepresented, or destroyed material information regarding the human health risks of such pesticide in order to obtain or maintain approval of its label by the EPA.” Tennessee is just one of 17 states lobbyists for Bayer have convinced to pursue new laws that would ban citizens’ abilities to pursue product liability lawsuits. Of those, only Georgia has passed the litigation through both its state houses and awaits the governor’s signature. At least 10 states currently have similar bills under debate. Six other states have rejected the proposals. Tags: Bayer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Supreme Court, Weed Killer Image Credit: Shutterstock – ZikG Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Roundup Stories Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 Roundup Non-Hodgkin’s Lymphoma Lawsuit Remanded From MDL for Trial July 25, 2025 New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermURLThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)